首页> 美国卫生研究院文献>Microbiology >Influence of a model human defensive peroxidase system on oral streptococcal antagonism
【2h】

Influence of a model human defensive peroxidase system on oral streptococcal antagonism

机译:人类防御性过氧化物酶系统模型对口腔链球菌拮抗作用的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Streptococcus is a dominant genus in the human oral cavity, making up about 20 % of the more than 800 species of bacteria that have been identified, and about 80 % of the early biofilm colonizers. Oral streptococci include both health-compatible (e.g. Streptococcus gordonii and Streptococcus sanguinis) and pathogenic strains (e.g. the cariogenic Streptococcus mutans). Because the streptococci have similar metabolic requirements, they have developed defence strategies that lead to antagonism (also known as bacterial interference). S. mutans expresses bacteriocins that are cytotoxic toward S. gordonii and S. sanguinis, whereas S. gordonii and S. sanguinis differentially produce H2O2 (under aerobic growth conditions), which is relatively toxic toward S. mutans. Superimposed on the inter-bacterial combat are the effects of the host defensive mechanisms. We report here on the multifarious effects of bovine lactoperoxidase (bLPO) on the antagonism between S. gordonii and S. sanguinis versus S. mutans. Some of the effects are apparently counterproductive with respect to maintaining a health-compatible population of streptococci. For example, the bLPO system (comprised of bLPO+SCN+H2O2) destroys H2O2, thereby abolishing the ability of S. gordonii and S. sanguinis to inhibit the growth of S. mutans. Furthermore, bLPO protein (with or without its substrate) inhibits bacterial growth in a biofilm assay, but sucrose negates the inhibitory effects of the bLPO protein, thereby facilitating adherence of S. mutans in lieu of S. gordonii and S. sanguinis. Our findings may be relevant to environmental pressures that select early supragingival colonizers.
机译:链球菌是人类口腔中的优势菌,在已鉴定的800多种细菌中约占20%,在早期生物膜定殖器中约占80%。口服链球菌包括与健康相容的菌株(例如戈登链球菌和血链球菌)和致病菌株(例如致龋性变形链球菌)。由于链球菌具有相似的代谢要求,因此他们开发了导致拮抗作用(也称为细菌干扰)的防御策略。变形链球菌表达对戈登氏链球菌和血红链球菌有细胞毒性的细菌素,而戈登氏链球菌和血红链球菌差异产生H 2 O 2(在有氧生长条件下),对变形链球菌具有相对毒性。宿主防御机制的作用叠加在细菌间的战斗上。我们在这里报告了牛乳过氧化物酶(bLPO)对戈登氏链球菌和血球链球菌与变形链球菌之间的拮抗作用的多种作用。对于维持健康相容的链球菌种群,某些影响显然会适得其反。例如,bLPO系统(由bLPO + SCN - + H2O2组成)破坏了H2O2,从而废除了戈登氏链球菌和血红链球菌抑制变形链球菌生长的能力。此外,bLPO蛋白(有或没有其底物)在生物膜测定中抑制细菌生长,但蔗糖抵消了bLPO蛋白的抑制作用,从而促进了 S的粘附。变形代替 S。 gordonii S。 sanguinis 。我们的发现可能与选择早期龈上定植者的环境压力有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号